Patent · US Active

Antibodies that bind human C6 and uses thereof

US10675348B2 · kind B2 · utility

2Cited by

0References

7Claims

0Family size

Assignee

REGENESANCE B.V. · NL

Inventors

Frank Baas · Hilversum, NL
Marc van Dijk · Bosch en Duin, NL

Key dates

Filing date	Jun 16, 2017
Grant date	Jun 9, 2020
Priority date	—
Expiry date	Feb 16, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N15/79
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Isolated monoclonal antibodies that bind to human complement component C6 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic methods for using the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.